|
Gene Information
Gene symbol: PRDX2
Gene name: peroxiredoxin 2
HGNC ID: 9353
Synonyms: PRP, NKEFB, TSA, PRXII, PRX2, MGC4104
Related Genes
Related Sentences
# |
PMID |
Sentence |
1 |
22160369
|
Only erythrocyte PRDX1 and PRDX2 proteins were detectable using immunohistochemical methods.
|
2 |
22160369
|
Furthermore, we studied the influence of a 3-month endurance training program (3 times a week, cycling at 75% maximal heart rate) on erythrocyte PRDX1 and PRDX2 contents in overweight/obese T2DM men (n = 11).
|
3 |
22160369
|
Only erythrocyte PRDX1 and PRDX2 proteins were detectable using immunohistochemical methods.
|
4 |
22160369
|
Furthermore, we studied the influence of a 3-month endurance training program (3 times a week, cycling at 75% maximal heart rate) on erythrocyte PRDX1 and PRDX2 contents in overweight/obese T2DM men (n = 11).
|
5 |
23093701
|
These include pyruvate kinase M1/M2, apolipoprotein A-I, albumin, peroxiredoxin 2, annexin A2, α-1-B-glycoprotein, flotillin-1 and haptoglobin.
|
6 |
23675018
|
Panretinal-Photocoagulation before Pars Plana Vitrectomy Influences Vitreous Level of Interleukin-6 but not of Vascular Endothelial Growth Factor in Patients with Diabetic Retinopathy.
|
7 |
23675018
|
Vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) in the vitreous sample were measured in each case.
|
8 |
23675018
|
After the completion of pre-treatment of PRP, macular edema defined as increase of foveal thickness was prominently worsened, and the vitreous level of IL-6 in PRP pre-treated group showed statistically higher than that in control.
|
9 |
23675018
|
In conclusion, PRP influenced vitreous level of IL-6 but not VEGF, leading to macular edema, which suggests that IL-6 plays critical roles of PRP induced macular edema.
|
10 |
23791845
|
Diabetic patients showed increased VAT abundance of glutathione S-transferase Mu 2, peroxiredoxin-2, antithrombin-III, apolipoprotein A-IV, Ig κ chain C region, mitochondrial aldehyde dehydrogenase and actin, and decreased abundance of annexin-A1, retinaldehyde dehydrogenase-1, and vinculin, compared with their non-diabetic counterparts.
|
|